| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.34B | — | +2.4% |
| R&D Expense | $143.0M | — | -6.5% |
| SG&A Expense | $861.0M | — | +18.1% |
| Operating Income | $259.0M | — | -58.8% |
| Pre-tax Income | $170.0M | — | -69.0% |
| Income Tax | -$96.0M | — | -186.5% |
| Net Income | $238.0M | — | -42.2% |
| EPS (Basic) | $0.29 | — | -38.3% |
| EPS (Diluted) | $0.28 | — | -40.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.37B | -11.8% | -19.3% |
| Accounts Receivable | $3.13B | +18.6% | +5.1% |
| Inventory | $2.58B | +3.9% | -2.5% |
| Current Assets | $9.02B | +5.7% | +6.8% |
| Total Assets | $37.19B | -0.0% | +2.0% |
| Current Liabilities | $8.59B | +20.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $79.0M | — | -83.6% |
| Investing Cash Flow | -$65.0M | — | -182.6% |
| Financing Cash Flow | -$141.0M | — | +94.9% |
| +22.5% |
| Long-term Debt | $10.42B | -8.3% | -5.9% |
| Total Liabilities | $23.39B | +1.4% | +5.1% |
| Stockholders' Equity | $13.80B | -2.3% | -2.8% |